Table 3.

Risk stratification according to gender.

Globorisk score	Total group (n = 71)		Male (n = 45)		Female (n = 26)
	At diagnosis	At the last visit	At diagnosis	At the last visit	At diagnosis	At the last visit
<3 points	15%	15%	45%	36%	54%	63%
3–10 points	39%	49%	50%	65%	50%	34%
>10 points	45%	35%	81%∗	72%∗∗	18%	28%

^∗ p = 0.01: men versus women at diagnosis, ^∗∗p = 0.01: men versus women after multimodal treatment at the last visit.